Skip to main content
Clinical Trials/NL-OMON35909
NL-OMON35909
Recruiting
N/A

Determination of presymptomatic disease features in Spinocerebellar Ataxia type 6 (SCA6) patients - PRESCA

Overview

Phase
N/A
Intervention
Not specified
Conditions
ADCA
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients: Subjects from 18 years and up with genetically diagnosed SCA6 without clinical symptoms of ataxia
  • Controls: Healthy subjects from 18 years and up.

Exclusion Criteria

  • Patients and controls:
  • Other neurodegenerative conditions than SCA6
  • Other conditions than SCA6 that influence gait
  • History of psychiatric or neurological disease
  • Deafness or hearing difficulties
  • Pregnant women and people with other contra\-indications for MRI will be included but in the study, but will not undergo MRI. In the case of pregnancy MRI will be planned around it.

Outcomes

Primary Outcomes

Not specified

Similar Trials